Back

Genetic determinants of coronary resilience: why do some high-risk individuals escape coronary artery disease?

28 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Biological determinants of atherosclerosis Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Francisco Sousa

Hospital Central do Funchal, Funchal (Portugal)

4 More presentations in this session

Presentation thumbnail
Polygenic risk score is associated with high-risk plaque and coronary plaque burden in patients with non-obstructive coronary artery disease
Ms E. Gaillard (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Glucose-to-potassium ratio independently predicts long-term adverse outcomes in patients with coronary artery disease after PCI
Miss K. Zhang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Olink proteomic inflammatory biomarkers enhance precision risk prediction for long-term outcomes in coronary artery disease
Miss K. Zhang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Coronary artery calcium predicts 5-year all-cause-, non-cardiovascular-, and cancer mortality
Professor J. Anderson (Murray, US)
Abstract Slides

Access the full session

Session thumbnail
Biological determinants of atherosclerosis

The Event

Event poster

ESC Congress 2026

28 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Association between genetic polymorphisms in multiple thrombosis-related genes and long-term prognosis in coronary artery disease patients: a large-scale cohort study
1 September 2025
thumbnail
Congress Presentation
Coronary risk reduction intervention for siblings and offspring of patients with premature coronary heart disease: the criso project.
3 April 2025
thumbnail
Congress Presentation
Genetic contribution to CAD in patients with few traditional risk factors but a sedentary lifestyle
29 August 2025
thumbnail
Congress Presentation
Extension of coronary artery disease and resistance to lipid-lowering treatment. Value of Lp(a)
23 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources